Camptocormia as Presenting Feature of Myotonic Dystrophy Type 2 (P10-11.017)

Authors

Olimpia Carbunar (ORCID: https://orcid.org/0009-0004-1065-5411)
Amaris Alayon
Mark Roberts (ORCID: https://orcid.org/0000-0003-2690-7658)

Institutions

University of Miami (US)
Jackson Health System (US)

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000211879
Primary Topic: Parkinson's Disease and Spinal Disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Camptocormia as Presenting Feature of Myotonic Dystrophy Type 2 (P10-11.017)

Olimpia Carbunar, Amaris Alayon, Mark Roberts

Apr 7, 2025

Neurology

Parkinson's Disease and Spinal Disorders

article

Camptocormia as Presenting Feature of Myotonic Dystrophy Type 2 (P10-11.017)

Olimpia Carbunar, Amaris Alayon, Mark Roberts

April 7, 2025article en

Abstract

No abstract available for this paper.

NeurologyVol. 104(7_Supplement_1)

University of Miami (US), Jackson Health System (US)

Openalex Percentile: Top 88%

Parkinson's Disease and Spinal Disorders

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Camptocormia as Presenting Feature of Myotonic Dystrophy Type 2 (P10-11.017) — Olimpia Carbunar, Amaris Alayon, et al. · Neurology (2025) | TGRS Research Map | TGRS